Emflaza

Deflazacort

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。
more
パッケージ あたり 錠剤 価格 節約 ご注文
180 tablet
¥ 113.64
¥ 20455.51¥ 113.64
¥ 36165.09
120 tablet
¥ 131.11
¥ 15733.19¥ 131.11
¥ 22013.87
90 tablet
¥ 157.32
¥ 14159.08¥ 157.32
¥ 14151.21
60 tablet
¥ 196.63
¥ 11797.92¥ 196.63
¥ 7075.61
30 tablet
¥ 314.56
¥ 9436.77¥ 314.56
パッケージ あたり 錠剤 価格 節約 ご注文
120 tablet
無料航空便配送 Hot
¥ 721.40
¥ 86567.96¥ 721.40
¥ 15709.58
90 tablet
無料航空便配送 Hot
¥ 760.73
¥ 68465.74¥ 760.73
¥ 8242.41
60 tablet
無料航空便配送 Hot
¥ 786.92
¥ 47215.31¥ 786.92
¥ 3923.46
36 tablet
無料航空便配送 Hot
¥ 830.56
¥ 29900.14¥ 830.56
¥ 783.12
24 tablet
¥ 852.31
¥ 20455.51¥ 852.31
パッケージ あたり 錠剤 価格 節約 ご注文
90 tablet
無料航空便配送 Hot
¥ 874.42
¥ 78697.43¥ 874.42
¥ 15719.42
60 tablet
無料航空便配送 Hot
¥ 944.33
¥ 56659.95¥ 944.33
¥ 6284.62
36 tablet
無料航空便配送 Hot
¥ 1005.46
¥ 36196.57¥ 1005.46
¥ 1570.17
24 tablet
無料航空便配送 Hot
¥ 1049.08
¥ 25177.83¥ 1049.08
Emflaza

ブランド

製造元

  • Lupin

病衣

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.